TY  -  
T1  - Biologisten lääkkeiden kustannusvaikuttavuus nivelreuman hoidossa : järjestelmällinen kirjallisuuskatsaus 
SN  -  /  
UR  - URN:NBN:fi-fe201801151332; http://hdl.handle.net/10138/161058 
T3  -  
A1  - Joensuu, Jaana 
A2  -  
PB  - Helsingfors universitet 
Y1  - 2013 
LA  - fin 
AB  - Rheumatoid arthritis (RA) is a chronic autoimmune disease with prevalence of 0.8% among Finnish adult population. Consequent medical treatment, joint replacement surgery and productivity losses lead to significant expenses for society. While biological treatments for RA are costly, they can improve patients' quality of life and work participation. Economic evaluations provide information on the benefits and costs of these expensive treatments to aid optimal utilization of limited healthcare reso... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - rheumatoid arthritis; biological treatment; cost-effectiveness; systematic literature review; nivelreuma; biologinen lääke; kustannusvaikuttavuus; järjestelmällinen kirjallisuuskatsaus; Socialfarmaci; Social Pharmacy; Sosiaalifarmasia 
N1  -   
PP  -  
ER  -